BeOne Medicines AG (ONC)
Healthcare • Biotechnology
StockNasdaqGSSwitzerlandUS07725L1026
412.67 USD
-0.79% today Updated 13 Nov 2026 16:05
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by BeOne Medicines AG, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:05. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 2.54
Last results
3.28 vs 1.88 estimated
05 Nov 2026 · Beat +74.3%
Beat the estimate
8 of 12
3 missed · 1 in line · 3 beats in a row
Average surprise
+45.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 2.54 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 1.88 | 3.28 | +74.3% | Beat |
| 05 Aug 2026 06:00 | 1.63 | 2.05 | +25.7% | Beat |
| 06 May 2026 06:00 | 0.81 | 1.96 | +143.3% | Beat |
| 26 Feb 2026 06:00 | 1.30 | 0.58 | -55.3% | Miss |
| 06 Nov 2025 06:00 | 0.86 | 1.09 | +27.0% | Beat |
| 06 Aug 2025 06:00 | 0.26 | 0.84 | +224.3% | Beat |
| 07 May 2025 06:00 | -0.74 | 0.01 | +101.4% | Beat |
| 27 Feb 2025 06:00 | -1.02 | -1.43 | -40.5% | Miss |
| 12 Nov 2024 06:00 | -1.11 | -1.15 | -3.2% | Miss |
| 07 Aug 2024 06:00 | -2.14 | -1.15 | +46.3% | Beat |
| 08 May 2024 06:00 | -2.54 | -2.41 | +5.3% | Beat |
| 26 Feb 2024 07:00 | -3.45 | -3.48 | -0.8% | In line |
| 09 Nov 2023 16:00 | -2.93 | 2.01 | +168.6% | Beat |
| 02 Aug 2023 06:00 | -2.98 | -3.64 | -22.2% | Miss |
| 04 May 2023 07:00 | -3.66 | -3.34 | +8.8% | Beat |
| 27 Feb 2023 07:00 | -4.06 | -4.29 | -5.7% | Miss |
| 09 Nov 2022 07:00 | -3.77 | -5.39 | -43.1% | Miss |
| 04 Aug 2022 07:00 | -4.01 | -5.56 | -38.7% | Miss |
| 05 May 2022 07:00 | -4.47 | -4.24 | +5.2% | Beat |
| 25 Feb 2022 07:00 | -3.83 | -6.16 | -60.8% | Miss |
| 04 Nov 2021 16:00 | -4.70 | -4.46 | +5.1% | Beat |
| 05 Aug 2021 16:00 | -3.99 | -5.23 | -31.1% | Miss |
| 06 May 2021 16:00 | -1.65 | 0.69 | +141.7% | Beat |
| 25 Feb 2021 16:00 | -4.22 | -5.20 | -23.1% | Miss |
| 05 Nov 2020 16:00 | -4.18 | -4.81 | -15.1% | Miss |
| 06 Aug 2020 16:00 | -4.72 | -4.31 | +8.7% | Beat |
| 11 May 2020 16:00 | -4.85 | -4.70 | +3.0% | Beat |
| 02 Mar 2020 16:00 | -4.53 | -6.39 | -41.2% | Miss |
| 12 Nov 2019 16:00 | -3.56 | -5.11 | -43.3% | Miss |
| 08 Aug 2019 16:00 | -3.01 | -1.43 | +52.5% | Beat |
| 09 May 2019 16:00 | -3.14 | -2.81 | +10.7% | Beat |
| 27 Feb 2019 16:00 | -2.99 | -4.52 | -51.0% | Miss |
| 07 Nov 2018 07:00 | -2.97 | -2.53 | +14.9% | Beat |
| 09 Aug 2018 05:00 | -2.12 | -2.92 | -37.9% | Miss |
| 09 May 2018 16:00 | -1.74 | -2.03 | -16.8% | Miss |
| 28 Feb 2018 16:00 | -1.75 | -2.19 | -25.4% | Miss |
| 13 Nov 2017 16:00 | -1.39 | 2.54 | +282.7% | Beat |
| 09 Aug 2017 16:00 | -1.20 | -1.52 | -27.0% | Miss |
| 10 May 2017 16:00 | -0.87 | -1.27 | -45.4% | Miss |
| 22 Mar 2017 16:00 | -0.86 | -1.05 | -22.5% | Miss |
| 10 Nov 2016 08:00 | -0.78 | -1.08 | -38.5% | Miss |
| 10 Aug 2016 16:00 | -0.67 | -0.73 | -8.2% | Miss |
| 11 May 2016 16:00 | -0.63 | -0.97 | -53.2% | Miss |
| 30 Mar 2016 16:00 | -1.06 | -3.05 | -187.7% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 5.3B | +40.2% | 286.9M | 5.4% | 2.47 | +140.3% | 861.1M |
| 2024 | 3.8B | +55.0% | -644.8M | -16.9% | -6.12 | +27.5% | -669.8M |
| 2023 | 2.5B | +73.7% | -881.7M | -35.9% | -8.45 | +56.4% | -1.8B |
| 2022 | 1.4B | — | -2B | -141.5% | -19.37 | — | -2B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 365.29 | 424.73 | 347.61 | 412.67 | +11.43% | 5,388,625 | |
| Oct 2026 | 367.94 | 388.66 | 340.45 | 370.33 | +1.20% | 8,193,400 | |
| Sep 2026 | 351.73 | 376.50 | 336.95 | 365.94 | +1.77% | 8,229,000 | |
| Aug 2026 | 316.01 | 380.00 | 309.93 | 359.58 | +13.79% | 8,470,000 | |
| Jul 2026 | 286.00 | 331.69 | 283.32 | 316.01 | +10.89% | 8,135,800 | |
| Jun 2026 | 287.55 | 291.74 | 253.95 | 284.97 | -1.02% | 6,460,600 | |
| May 2026 | 295.27 | 322.45 | 287.53 | 287.92 | -2.49% | 4,812,500 | |
| Apr 2026 | 303.92 | 328.39 | 289.54 | 295.27 | -0.57% | 4,305,000 | |
| Mar 2026 | 305.50 | 315.00 | 271.47 | 296.97 | -6.32% | 5,435,000 | |
| Feb 2026 | 333.11 | 372.73 | 314.23 | 316.99 | -6.87% | 5,110,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Titus Ball Takes Money Off The Table, Sells $632K In BeOne Medicines Stock (opens in a new tab) Benzinga · 11 Nov 2026 11:01
- BeOne Medicines AG 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 09 Nov 2026 18:44
- RBC Capital Maintains Outperform on BeOne Medicines, Raises Price Target to $465 (opens in a new tab) Benzinga · 06 Nov 2026 13:57
- Truist Securities Reiterates Buy on BeOne Medicines, Raises Price Target to $448 (opens in a new tab) Benzinga · 06 Nov 2026 13:51
- BeOne Medicines Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 13:14
- Barclays Maintains Overweight on BeOne Medicines, Raises Price Target to $446 (opens in a new tab) Benzinga · 06 Nov 2026 12:04
- Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $463 (opens in a new tab) Benzinga · 06 Nov 2026 11:33
- Wells Fargo Maintains Overweight on BeOne Medicines, Raises Price Target to $435 (opens in a new tab) Benzinga · 06 Nov 2026 10:52
- BeOne Medicines Ltd (ONC) Q3 2026 Earnings Call Highlights: Brukinsa Tops $1 Billion in U.S. ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 23:19
- Compared to Estimates, BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 05 Nov 2026 21:30
- Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch? (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:22
- BeOne Medicines AG (ONC) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 16:24
- BeOne Medicines Announces Third Quarter 2026 Financial Results and Business Updates (opens in a new tab) 05 Nov 2026 11:00
- BeOne Medicines Raises FY2026 Sales Guidance from $6.600B-$6.800B to $6.900B-$7.000B vs $6.763B Est (opens in a new tab) Benzinga · 05 Nov 2026 07:03
- U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma (opens in a new tab) 04 Nov 2026 14:13
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 415.96 USD
- Market cap
- 47.1B
- Exchange
- NasdaqGS
- Country
- Switzerland
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ONC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.